Skip Navigation
Johns Hopkins Bloomberg School of Public HealthCAAT

Presentations -- Alan M. Goldberg, PhD.

Invited Seminars:


  • IFRA, Board of Directors, April
  • IFRA, Scientific Advisor, June
  • Seymour Essorg Memorial Lecture, November


  • Presentation on Objectives of the Conference: “DNT: a Puzzle or a Mystery” at DNT3 International Conference – “Advancing the science of developmental neurotoxicity testing for better safety evaluation,” Varese, Italy, May
  • Keynote lecture: The CAAT Experience: Humane science is the best science, IVTIP Spring Meeting, “In vitro reconstructed human tissue models as alternatives to animal testing: applicability and limitations,” Monte Carlo, Monaco, April
  • Presentation on “The CAAT Experience: Human science is the best science,” announcement of the Alexandra Project, Monte Carlo, Monaco, April
  • Presentation at DNT3 Conference, “Objectives of the Conference: DNT: a puzzle or a mystery,” Varese, Italy, May


  • Presentation on “The New Toxicology” at Innovation for Sustainable Production (I-Sup 2010), Belgium, April


  • Presentation at Alberto-Culver on “Animal Alternatives & Humane Science for the Cosmetic Industry” for Marketing and Business Groups; and “Humane Science & Alternatives to Animal Testing for the Cosmetic Industry” for Research and Development Group, Chicago, February
  • Presentation at the University of Nottingham on the 50th Anniversary of the publication of The Principles of Humane Experimental Technique by WMS Russell & RL Burch, “Animal Experimentation and the Three Rs: Past, Present and Future, Nottingham, UK, June
  • Presentation at 7th World Congress on Alternatives & Animal Use in the Life Sciences, 50 Years After Russell & Burch Lecture: “The Principles of Humane Experimental Technique: Is it relevant today?” Rome, September
  • 2008
  • CAAT/UCLA Alternative Models for Animal Research Workshop: “The Science of Alternatives: Initial Truths and Current Realities,” California, January
  • Seminar: “Toxicity Testing for Hazard ID and Dose Response in Risk Assessment: Current Practice and Strategy for the Future,” with Dr James Yager, BSPH, February
  • Panel Discussion of ethical issues that arise in research with animals, for Dr Nancy Kass’ Research Ethics & Integrity Course with Dr Kass and Anna Durbin, BSPH, February
  • AAAS Annual Meeting: Presentation on “The Science Behind Consumer Product Safety Testing: New Directions,” Boston, February
  • Presentation at RIFM on “Current Status of Alternatives, New Jersey, March
  • Society of Toxicology Annual Meeting: Presentation on “Humane Science: Refinement Alternatives,” San Francisco, March
  • IACUC Advanced Workshop presented by SCAW, Presentation on “Advances in Toxicological Measurement: Modifications of Current Toxicological Methods to Alleviate Pain and Distress,” Bethesda, May
  • Presentation to NAMSA Corporation Board on “Status of Alternatives in the United States,” Ohio, August
  • Presentation at IVTIP Autumn Meeting, “The US and in vitro toxicology: past the tipping point,” Brussels, November
  • Presentation to Clorox Services Company, San Francisco, November
  • Presentation to Korean Association for Laboratory Animal Science (KALAS) Joint Fall Symposium with Institute for the 3Rs @ Konkuk University, Special Lecture on Humane Sciences: History & Practice and lecture on Alternatives: Science & Policy, Seoul, Korea, November


  • First Indian Congress on Alternatives to the Use of Animals in research, testing and education. Presentation on the “Science of Alternatives” Chennai, India, January
  • Society of Toxicology 46th Annual Meeting: Informational Session Presentation: Communication and Animal Protection, Charlotte, NC, March
  • Toxicology Forum: Presentation on “How can we best evaluate Neurodevelopmental Toxicity?” Aspen, CO, July
  • International Congress of Toxicology: Discovery Serving Society: Continuing Education Course, “The Science of Alternatives.” Montreal, Canada, July
  • Seminar at Loyola University Medical Center, “Animals, Science and Society”(The Israel Hanin Lecture) Chicago, IL, August
  • 6th World Congress on Alternatives & Animal Use in the Life Sciences, “Science of Alternatives – The Last 25years and tomorrow” and “Science of Alternatives – A Public Lecture,” Tokyo, Japan, August
  • European NanOSH Conference presentation by Ellen Silbergeld. “Looking as we leap: prudent risk assessment for nanotechnologies” Authored with Ellen Silbergeld, Jennifer Nyland, and Renee Gardner , December
  • 2006
  • Presentation at University of Maastricht, “The Science of Alternatives,” Netherlands, February
  • Seminar at Syngenta, London, England, February
  • SOT Symposium, “The Biological Matrix of In Vitro Systems and their use in Toxicology, with Sid Green, San Diego, March
  • Presentation at Animal Grantmakers Association Meeting, “Alternatives to Animal Testing and Laboratory Animal Medicine,” with Dan Weary,
  • Vancouver, British Columbia, November
  •  Lecture at University of British Columbia, November


  • Presentation at Society of Toxicology meeting in New Orleans, March
  • Presentation at PRIM&R meeting in San Diego, March
  • ATCC Science Forum Lecture, Virginia, March
  • Presentation to animal research community at Virginia Commonwealth University, Richmond, May
  • Presentation at Yale University, "Genomic Priorities in Public Health," New Haven, Connecticut, June
  • Presentations at 5th World Congress on Alternatives and Animal Use in the Life Sciences, "Forum of national and international institutions funding research according to the 3Rs," and "TestSmart-DNT," Berlin, Germany, August
  • Presentation at European Parliament, "Europe Goes Alternative," Brussels, November
  • Presentation at CTFA Workshop, "Systemic Toxcity Overview and Developmental Neurotoxicity," New Jersey, November
  • Presentation to Ethicon Division of Johnson & Johnson, "Correlating Preclincal Models to Clinical Outcomes," New Jersey, December


  • Presentation at SCAW Meeting, "Enhancing Humane Science/Improving Animal Research", San Antonio, March
  • Presentation at PRIM&R Meeting, "Enhancing Humane Science/Improving Animal Research7qu , Boston, March
  • Presentation at Johns Hopkins University School of Medicine, "Enhancing Humane Science/Improving Animal Research", Baltimore, March
  • Presentation at Society of Toxicology, "Enhancing Humane Science/Improving Animal Research", Baltimore, March
  • Presentation at University of Konstanz, "What is CAAT?" Germany, April
  • Presentation at Children's Hospital of Philadelphia, "Enhancing Humane Science/Improving Animal Research", Philadelphia, May
  • Presentation at AstraZeneca, "Enhancing Humane Science/Improving Animal Research", Delaware, June
  • Presentation at Shell Oil Company, "Enhancing Humane Science/Improving Animal Research", London, June
  • Presentation at FRAME meeting, "Enhancing Humane Science/Improving Animal Research", London, October
  • Presentation at Procter & Gamble, "Enhancing Humane Science/Improving Animal Research", Ohio, November
  • Presentation at JHU SOM Town Hall Meeting, "Enhancing Humane Science/Improving Animal Research", Baltimore, November
  • Presentation at Refinement Meeting, "Enhancing Humane Science/Improving Animal Research", Utrecht, The Netherlands, November


  • Presentation at MRC Toxicology Unit, Centre for Best Practice for Animals in Research Stakeholders Statistical Education Meeting, "Reduction and the Use of Laboratory Animals — An American Perspective," Leicester, February
  • Presentation at American Society for Neurochemistry Workshop, Newport Beach, California, May
  • Presentation at American Red Cross Seminar, Rockville, Maryland, May
  • Presentation at International Neurotoxicology Association Meeting, "In Vitro and Alternative Approaches to Developmental Neurotoxicity Testing (DNT)" with Pamela Lein, Paul Locke and Ellen Silbergeld, Dresden, Germany, June
  • Presentation at ECVAM Workshop, "Strategies to replace in vivo systemic toxicity testing," Ispra, Italy, September
  • Presentation at Utrecht University Farewell to Bert van Zutphen, "Animals in Biomedical Research: Replacement, Reduction, Refinement," The Netherlands, October
  • Presentation at SCAW Conference, "The Science of Humane Study Design," San Antonio, Texas, December


  • Symposium: Doerenkamp-Zbinden/German Pharmacological Society on Experimentation employing Animals and Men: What is necessary, permitted and needed? — presentation: American Perspective: Animal Welfare Issues, Mainz, Germany, March
  • Society of Toxicology Annual Meeting, In Vitro Specialty Section Symposium: The 3Rs of Alternatives: Humane Science — The Best Science, Nashville, March
  • Presentation to House of Lords, London, England, April
  • Presentation to Animal Welfare Officers, Netherlands, May
  • Presentation to EU Commission, Brussels, June
  • Presentation to 4th World Congress on Alternatives, New Orleans, August
  • Presentation to ILSI HESI Subcommittee on Agricultural Chemical Safety Assessment, Washington, DC, October


  • Society of Toxicology Annual Meeting, San Francisco, March
  • AstraZeneca Veterinary Symposium, Montreal, Canada, July


  • PRIM&R Annual Meeting, Boston, Henry Spira Memorial Lecture, "Implementing Humane Endpoints in Research Protocols," March
  • Society for Chemical Hazard Communication Meeting, Arlington, "Current Perspectives on the Development of Alternative Toxicity Testing Methods," September
  • The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and The National Toxicology Program International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity — Invited Expert, October
  • Johnson & Johnson "Alternative Approaches to Animal Testing Symposium," October
  • Toxikon Corporation, "In Vitro Testing Alternatives Seminar," November
  • The Effects of International Change on Laboratory Animal Science and IACUCs in the United States, Canada & the UK, SCAW Conference, San Antonio, December


  • Howard University, Washington, D.C., "Use of Animals in Toxicology: Principles of the Three Rs," April
  • CIIT Annual Meeting, Cary, N.C., "The Three Rs of Alternatives in Toxicology," May
  • Zeneca Pharmaceuticals, Wilmington, DE., "AltWeb," May
  • 3M, "TestSmart — A case study to develop 3R alternative protocols; The 3Rs of Alternatives — Principles and Practice," Minnesota, May
  • Society of Plastics Annual Meeting, "Changing Face Of Research: Alternatives to Animal Testing," Baltimore, MD, June
  • 3rd World Congress on Alternatives and Animal Use in the Life Sciences, several presentations, Bologna, Italy, September
  • ECVAM Symposium on Integrated Testing, "TestSmart: An Integrated Strategy for HPV Chemicals", Ispra, Italy, September
  • SCAW/Wards Seminar at AALAS Annual Meeting, "Toxicology Testing Issues & Alternatives," Indianapolis, November


  • Society of Toxicology Annual Meeting, Seattle Washington, March
  • Zeneca Pharmaceuticals, Animals and Alternatives, England, May
  • Unilever, Animals and Alternatives, England, May
  • Use of Animals in Biomedical Research, Andrews Air Force Base, Maryland, May
  • Procter & Gamble, Animals and Alternatives, England, June
  • Rhone Poulenc Rorer, Animals and Alternatives, France, July
  • CAAT/NIH/OPRR Workshop on Pain Management and Humane Endpoints, Washington, DC, November
  • OECD Conference on Humane Endpoints, Netherlands, November
  • Alternative Toxicological Methods for the 21st Century, Bethesda, December


  • SGOMSEC 13 Workshop: Alternative Testing Methodologies, Ispra, Italy, January.
  • Vistakon, Jacksonville, Florida, April.
  • 2nd International Symposium on Cosmetic Efficacy, New York, New York, April.
  • Johns Hopkins University Department of Biomedical Engineering, Baltimore, May.
  • Pharmaceutical Research and Manufacturers of America (PhRMA), Operational Issues from an Academic Perspective, Baltimore, May.
  • Department of the Air Force, Use of Animals in Biomedical Research, Andrews Air Force Base, Maryland, May.
  • Zeneca Pharmaceuticals, "The Impact of Alternatives in Medical Research," Wilmington, Delaware, June.
  • CAAT: Past, Present & Future, Joint CAAT/IIVTG Symposium, September


  • Validation/Legislation and numerous other presentations at the 2nd World Congress on Alternatives and Animal Use in the Life Sciences, Utrecht, Netherlands, October
  • "Background of CAAT" presentation to 3M Corporation, Minneapolis, Minnesota, July
  • "Lab Animal Research" presentation to Hoffman La-Roche Company, Newark, New Jersey, June
  • Presentation at SCAW Conference, Baltimore, Maryland, June
  • Presentation to DuPont Corporation, Wilmington, New Jersey, May
  • Presentations at CAAT/ECVAM Workshop, Italy, April
  • "The importance of in vitro methods for pharmaco-toxicological application," presentation to Swiss Tissue Culture Society Workshop in Switzerland, March


  • Seminars on Topics of In Vitro Toxicology
  • A Modular Approach to Validation of In Vitro Methodology, CAAT Symposium, Baltimore, Maryland
  • Alternatives in Toxicology: Friend or Foe?, CIIT, Research Triangle Park, North Carolina
  • Development of Alternative Methods and the Modular Approach to Validation, ICLAS, Madrid, Spain
  • Human Experimental Techniques in the Life Sciences, Kitasato University, Tokyo, Japan
  • Alternatives in Toxicology - The Need for Mechanistic Data, Japanese SOT, Tokyo, Japan
  • Alternatives in Toxicology: Friend or Foe?, Hatano Research Institute, Food & Drug Safety Center, Hadano, Japan
  • Alternatives in Toxicology - Seminar at Hoffman LaRoche, New Jersey
  • The 3 Rs (Alternatives) in Toxicology, Seminar at DuPont, Wilmington, Delaware


  • Seminars on Topics of In Vitro Toxicology
  • Alternatives in the Assessment of Toxicity: Theory & Practice - Aberdeen Proving Ground, MD
  • Modulation of Cellular Responses in Toxicity - International Business Communications - Bethesda, MD
  • In Vitro Toxicology - Validation Issues - National Area Tissue Culture Assoc., College Park, MD
  • In Vtro Toxicological Testing - Validation, SCC Annual Seminar, Las Vegas, NV
  • In Vitro Toxicology - Xenometrix, Boulder, CO
  • Validation of In vitro methods - INVITOX, Zurich, Switzerland
  • Seminars on Topics of Animal Issues
  • Panel "The Limits of Protest: Debate, Demonstrations, Intimidation and/or Terrorism - How do we Draw the Boundaries" - Prim&R - Boston, MA
  • "The Use of Animals In Biomedical Research and Teaching: Where do we stand?, FASEB, Anaheim, CA
  • "Alternatives to Animal Testing", FDA Science Forum on Regulatory Sciences, Washington, DC
  • Seminars on Technology Transfer
  • Risk Management Seminar; Alternatives to Animal Research - 3M Corp. Minneapolis, MN
  • "Responsible Conduct of Research", Graduate Faculty Meeting, McGill Univ., Montreal, Canada


  • Seminars on Topics of In Vitro Toxicology
  • In Vitro Approaches to Product Development & Safety Evaluation - Washington, DC
  • The Need for Mechanistic Data In In Vitro Toxicology, NIEHS, Research Triangle Park, NC
  • Validation Issues - ILSI Org. Meeting on In Vitro Alternatives - Washington, DC
  • Current Trends: In Vitro Skin Toxicology and Eye Irritancy Testing- Ottawa, Canada
  • Seminars on Technology Transfer
  • Department of Commerce, Washington, DC
  • Forum on Grantsmanship and Sources for Research Support - SOT Meeting, New Orleans, LA


  • Seminars on Topics of In Vitro Toxicology
  • In Vitro Skin Irritation; Issues on Use of In Vitro Systems - Arlington, Virginia
  • U.S. Army Chemical Research, Development and Engineering Center - APG, Maryland
  • Issues In In Vitro Toxicology - USC, Pasadena, California
  • Alternatives to the Draize Test - Sedona, Arizona
  • World Economic Forum - Davos, Switzerland
  • Medical Libraries Association - Washington, DC
  • Seminars on Topics of In Vitro Toxicology
  • Prim&R Workshops (2) - Boston, Massachusetts
  • Catholic University of Louvin - Brussels, Belgium


  • Seminars on Topics of In Vitro Toxicology
  • Bristol-Myers Squibb Company - Princeton, New Jersey
  • New Jersey AALAS - Princeton, New Jersey
  • Division of Toxicological Sciences, Johns Hopkins University School of Public Health - Baltimore, Maryland
  • Public Health Service of Holland
  • University of Pisa - Pisa, Italy
  • Gronengen Holland
  • Seminars on Topics of Animal Issues
  • Management Development Seminar; University of Maryland at Baltimore - Cockeysville, Maryland
  • Public Responsibility in Medicine & Research Annual Meeting - Boston, Massachusetts
  • FASEB, Annual Meeting - Atlanta, Georgia
  • Great Lakes Chapter of ASPET - Rosemont, Illinois
  • Sigma Xi, The Scientific Research Society - The Johns Hopkins University Chapter
  • Alternatives to Animal Testing; NIH Administrators
  • University of Utrecht
  • Merck Corporation
  • World Veterinary Congress - Rio de Janiero, Brazil
  • Honorary Lectures
  • Chevron Lecture - University of California at Davis, Davis, California
  • Russell & Burch Lecture - Humane Society of the United States, Washington, DC


  • Seminars on Topics of In Vitro Toxicology
  • American Association for the Advancement of Science, New Orleans, Louisianna
  • Research Institute of Toxicology - Keynote Address- University of Utrecht, Netherlands
  • Cornell University - Ithaca, New York
    School of Veterinary Medicine, Students for Animal Rights
  • Bristol-Myers Squibb, Co. - Hartford, Connecticut
  • National Cosmetology Association - Washington, DC
  • Abbott Laboratories - Abbott Park, Chicago
  • SRI International - Palo Alto, California
  • National Association for Biology Teachers - Houston, Texas
  • International Research & Development Corporation - Mattawan, Michigan
  • Allergan Pharmaceutical - Irvine, California


  • Seminars on Topics of In Vitro Toxicology
  • Governor's Task Force on Animal Issues - Baltimore, Maryland
  • Drug Forum, Institute of Medicine - Washington, DC
  • Australian Society for Cosmetic Chemistry - Keynote Address- Wissina, Australia
  • Melbourne Institute Technology Key Centre for Toxicology - Melbourne, Australia
  • Worksafe Australia - Sydney, Australia
  • Flinders University of South Australia - Adelaide, Australia
  • Mc Gill University - Ontario, Canada
  • Food & Drug Law Institute - Washington, DC
  • 1988
  • Seminars on Topics of In Vitro Toxicology
  • USP - Marco Island, Florida
  • University of Pennsylvania, School of Medicine - Philadelphia, Pennsylvania
  • Sterling Drug - Albany, New York
  • Ciba-Geigy - Summit, New Jersey
  • Clonetics - San Diego, California
  • Otsuka Pharmaceutical - Tokushima, Japan
  • Alternative Futures - Washington, DC
  • Molecular Devices - San Jose, California
  • Public Health and Neuroscience Research - Hamamatsu, Japan


  • Seminars on Topics of In Vitro Toxicology
  • The 32nd OHOLO International Conference - Israel
  • ICI Americas, Inc. - Stuart Pharmaceutical - Wilmington, Delaware
  • Purdue University Pharmacology & Toxicology Seminar - West Lafayette, Indiana
  • National Research Council - Board on Basic Biology - Committee on the Use of Laboratory Animals in Biomedical and Behavioral Research - Washington, DC
  • Pharmaceutical Manfacturers Association Biological Section Spring Meeting - Scottsdale, Arizona
  • CTFA Expert Panel Meeting - Washington, DC
  • Animal Health Institute Mid-Year Animal Drug Meeting - Captiva Island, Florida


  • Seminars on Topics of In Vitro Toxicology.
  • Society of Toxicology - Neurotoxicology - New Orleans, Louisiana
  • Society of Cosmetic Chemists - COSA - Boston, Massachusetts
  • International Seminar on Chemicals Testing and Animal Welfare - Stockholm, Germany
  • Satellite Symposium on Toxicity Testing of Industrial Chemicals - Tokyo, Japan
  • Otsuka Assay Laboratories - Tokushima, Japan
  • Health Research Foundation - Tokyo, Japan
  • Kitasato University - Tokyo, Japan
  • Daiichi Seikayu Company Research Institute - Tokyo, Japan
  • Toyo Jozo Company - Mishma, Japan
  • Sterling Winthrop Research Institute - Rensselaer, New York
  • The 31st OHOLO International Conference - Israel


  • Seminars on Topics of In Vitro Toxicology.
  • Environmental Protection Agency - Washington, DC
  • Food and Drug Administration - Washington, DC
  • Ralston Purina Company - St. Louis, Missouri
  • Amoco Company - Chicago, Illinois
  • Hadassah Hospital - Jerusalem, Israel
  • Hebrew University - Jerusalem, Israel
  • Rutgers University - New Brunswick, New Jersey
  • International Life Sciences Institute - Nutrition Foundation - Atlanta, Georgia
  • American Chemical Society - Chicago & Washington, DC
  • International Minerals and Chemicals Corporation - Chicago, Illinois
  • Mechanism of Neurotoxicology
  • Chronic Disease Epidemiology - The Johns Hopkins University - Baltimore, Maryland Hebrew University - Jerusalem, Israel
  • Neurobiology of Acetycholine Symposium, Loyola University - Chicago, Illinois


  • Seminars on Topics of In Vitro Toxicology
  • Hoffman-LaRoche, Nutley, New Jersey
  • University of North Carolina, Raleigh, North Carolina
  • International Workshop on Irritancy Testing - Frauenfeld, Switzerland
  • Johns Hopkins Society of Alumni - Baltimore, Maryland
  • Society of Cosmetic Chemists - Los Angeles, California
  • Department of Neurology, Johns Hopkins University - Baltimore, Maryland
  • Toxicology Information Subcommittee of DHHS - N.L.M. - Washington, DC
  • Policy and Science - FEMA - Washington, DC
  • Scientists Center for Animal Welfare - Laboratory Animal Management - Johns Hopkins University, Baltimore, Maryland
  • Joint American-Swiss Seminar on Alternative Embryotoxicity & Teratogenicity Tests - Zurich, Switzerland
  • Society of Toxicology of Canada - Montreal, Canada
  • Albany Medical College - Albany, New York
  • Biochemistry Open Seminar - Johns Hopkins University - Baltimore, Maryland
  • Hopkins International Forum - Johns Hopkins University - Baltimore, Maryland
  • Pharmacology & Toxicology Æ84 - Brooklyn College of Pharmacy, Brooklyn, New York
  • Society of Toxicology - Mid-Atlantic Chapter, New York
  • Sterling Winthrop - Albany, New York
  • Mechanism of Neurotoxicology
  • The American Industrial Hygiene Association - Pennsylvania Regional Chapter Academic Industrial Relationships
  • George Washington University Faculty Assembly - Washington, DC


  • Seminars on Topics of In Vitro Toxicology
  • University of Cincinnati, Kettering Laboratories
  • University of Texas Medical Center at Dallas, Faculty Senate
  • University of Rochester, The Toxicology Program
  • Society of Toxicology, National Meeting
  • American Association for the Advancement of Science, National Meeting
  • American Society for Pharmacology and Experimental Therapeutics, Fall Meeting
  • Syntex Laboratories, Palo Alto, California
  • Haskell Laboratories, Newark, Delaware
  • Baltimore Animal Liberation, Baltimore, Maryland
  • Comparative Medicine Seminar, The Johns Hopkins Medical Institutions
  • Pharmaceutical Manufacturing Association Foundation, Chicago, Illinois
  • PRIM&R, Boston, Massachusetts
  • Institute for Bioscience, Boston, Massachusetts
  • Toxicity Testing Symposia, London, England
  • Federal Republic of Germany, Berlin, Germany


  • Presentations on the Center for Alternatives to Animal Testing
  • Society of Comparative Ocular Toxicology, New Jersey
  • Trade Association Scientific Directors, Washington, DC
  • Pharmaceutical Manufactures Association, Research and Development Committee, West Palm Beach, Florida
  • In Vitro International Toxicology Workshop, Stockholm, Sweden
  • International Information Center of Cosmetic Industries, Paris, France; FRAME, London, England,
  • AALAS, Rockefeller University, New York, New York
  • Society of Toxicology, Regional Chapter, Washington, DC
  • The Hollywood Dump
  • Institute to the Ministry of the Sick, Baltimore, Maryland
  • Preventive Medicine 1982, Baltimore, Maryland
  • Neurotoxicology
  • Presented in Chronic Disease Epidemiology, The Johns Hopkins University
  • In Vitro Toxicology Testing
  • The Toxicology Program, Rutgers University, New Jersey
  • Rockefeller Symposium, New York
  • American College of Toxicology, Washington, D.C.
  • Progress in Cholinergic Biology
  • Symposium, American Society for Neurochemistry, New York.
  • Symposium, Acetylcholine, Strassbourgh, France.


  • We'd Better Damn Sight Do Something About Chemical Dump Sites. Two Presentations for Johns Hopkins University Alumni, Princeton and New York Chapters, 1981.
  • Public Policy Address - When Does an Environmental Pollutant Become a Neurotoxin? Annual Meeting, American Society of Neurochemistry, March 1981. Richmond, Virginia.
  • Symposium on Nutritional Factors and Brain Mechanism - Precursor Control of Acetylcholine Synthesis. American Society of Neurochemistry, 1981, Richmond, Virginia
  • The Interaction of Choline Availability and Neuronal Activity on Acetylcholine Regulation. ISG - Zurich, Switzerland; Mario Negri Institute, Milan, Italy, Env. Protection Agency, Research Triangle Park, 1981; Catholic University, 1981
  • Neurotoxicity - In Chronic Disease.,Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland
  • From Baltimore to China to the Hollywood Dump. Presentation with Drs. Henderson, Horn, and Taylor to The Johns Hopkins Hospital, Womens Board Annual Meeting


  • Adverse Neurological Effects as a Result of Area-Wide Contamination. National Academy of Sciences, Washington, D.C.
  • Biology of the Active (Firing) Cholinergic Neuron. Department of Neurology, Johns Hopkins University. Biology of the Active (Firing) Cholinergic Neuron. Georgetown University.
  • Effects of Choline on Acetylcholine Release. Miles Symposium, Baltimore, Maryland.
  • Mechanisms of Toxicity Studied in Tissue Culture. Soesterberg, The Netherlands.
  • Neurotoxicology. Department of Epidemiology, Johns Hopkins University.
  • Neural Activity as a Determinant of Neuronal Function. Weitzman Institute, Israel.
  • Precursor Control of Neurotransmission. Div. Env. Chemistry, Johns Hopkins Univ., Baltimore, Maryland


  • Control of Acetylcholine Synthesis. Armed Forces Radiation Research Institute, Washington, DC
  • Neurotoxicity of Lead. Johns Hopkins School of Hygiene and Public Health, Biochemistry Department. Neurotoxicology of Lead. Army Environmental Inst., Aberdeen, Maryland
  • Control of Acetylcholine Synthesis. Massachusetts Institute of Technology.
  • Neurotoxicity of Lead. Mount Sinai Hospital, Baltimore, Maryland
  • Environmental Toxicology. University of Maryland.Environmental Toxicology. Aberdeen, Maryland.
  • Effects of Choline on Acetylcholine Release. Zurich, Switzerland.
  • Utility of In Vitro Preparations for the Study of Neurotoxicity. Washington, DC


  • Acetylcholine: Neurological Update. Department of Neurology, University of Miami, Florida
  • Lead Neurotoxicity. Department of Pharmacology, University of Maryland, Baltimore, Maryland
  • The Effects of Inorganic Lead on Cholinergic Transmission. Czechoslovakia Academy of Sciences, Czechoslavakia
  • Biology of Cholinergic Function. Merck, Inc., Pennsylvania.
  • Acetylcholine Release from the Neuromuscular Junction. City of Hope, National Medical Center, California.
  • The Effects of Choline on Acetylcholine Release from the Neuromuscular Junction. Tucson, Arizona.


  • Biologic Effects of Lead. Dutch Chemical Society, Section of Environmental Chemistry.
  • Cholinergic Effects of Lead. Agricultural University, Wageningen, The Netherlands.
  • Is Deanol a Precursor of Acetylcholine. International Symposium on the Management of Cholinergic Deficiency Syndromes, Jamaica.
  • Animal Models of Hyperactivity. Workshop on Animal Models in Neurology and Psychiatry, Washington, DC
  • Cholinergic Effects of Lead. University of North Carolina, Raleigh, North Carolina
  • Neurochemical Aspects of Early Exposure to Lead. Division of Comparative Medicine, The Johns Hopkins University, Baltimore, Maryland.


  • Neurotoxicity of Lead. University of South Carolina.
  • Neurotoxicity of Lead. McGill University.
  • Grand Rounds. (Pediatrics). The Johns Hopkins University.
  • An Animal Model of Hyperactivity. Squibb Institute for Medical Research.
  • Lead Poisoning. EPA - Biological Effects of Environmental Pollutants.
  • An Animal Model of Hyperactivity. University of Minnesota.
  • Kanaga Conference on Lead. Chairman and Participant on the Neurochemical Effects of Lead.
  • Neurotoxicity of Lead. University of Pittsburgh.


  • Neurotoxicity of Lead. Naval Medical Research Institute, Bethesda, Maryland.
  • Neurotoxicity of Lead. University of Kansas.
  • Neurotoxicity of Lead. University of Utrecht, The Netherlands.
  • Acetylcholine Metabolism in Brain. Vrije University, The Netherlands.
  • Acetylcholine Metabolism in Brain. Howard University.


  • Lead Poisoning. University of Pittsburgh, Department of Psychiatry, Western Psychiatric Institute and Clinic.
  • Inhibitors of Choline Acetyltransferase. University of Pittsburgh, School of Pharmacy.
  • Cholinergically Linked Diseases. Mid-Atlantic Acetylcholine Discussion Group.
  • Determination of Acetylcholine. Tel Aviv University, State of Israel.
  • Lead Poisoning and Hyperactivity. Prime Minister, Office of Ins. Biol. Res., State of Israel.
  • Cholinergic Aspects of Lead Poisoning. Hebrew University, Jerusalem, State of Israel.
  • Low Level Lead Poisoning. WHO - EPA and European Common Market, Paris.


  • Inhibitors of Choline Acetyltransferase. City of Hope Medical Center.
  • Hyperactivity - A Lead-Induced Behavior Disorder. NIEHS.
  • Lead Toxicity and Hyperactivity. Canadian Association for Research in Toxicology.
  • Lead-Induced Hyperactivity. Riker Laboratories.


  • Studies on the Snythesis of Acetylcholine. University of North Carolina, Wilmington.
  • Methods for the Determination of Acetylcholine. National Institutes of Mental Health, St. Elizabeth Hospital, Wash , D.C.
  • The Anticonvulsant Properties of 4-(1-Naphylvinyl) Pyridine. NIG Section of Epilepsy.
  • Is Choline Acetyltransferase in Excess in Mammalian Brain? University of Texas, Galveston.
  • Current Concepts in Cholinergic Chemistry. Smith, Kline and French Laboratories.
  • Recent Studies on Acetylcholine Metabolism. University of Maryland